News | January 23, 2013

DVT Clots Quickly, Safely Removed With Pharmacomechanical Thrombectomy, Study Suggests

January 23, 2013 – Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of treating deep vein thrombosis (DVT), suggests data being presented at the 25th annual International Symposium on Endovascular Therapy (ISET).

Rheolytic pharmacomechanical thrombectomy using combination therapy is fast and effective, reducing treatment time from more than two days to less than 24 hours, suggest phase II results of the multi-center PEARL registry.

As many as 600,000 people annually suffer from DVT, or blood clots in the large veins of the leg or abdomen, according to the Centers for Disease Control and Prevention (CDC). Small pieces of the clot can break off, travel to the lungs and cause pulmonary embolism (PE), which kills as many as 100,000 people a year. DVT can develop when people are immobile for long periods (such as on a long flight) or severely dehydrated. Other risk factors include genetic conditions that cause the blood to clot too easily or obstructions in the pelvic veins.

People with DVT typically are treated with blood thinners. Often this treatment is only partially effective at removing the clot, which can cause lifelong pain, swelling and blood flow problems.

“We’re on the verge of a truly outpatient procedure for the treatment of DVT,” said Robert Lookstein, M.D., chief of interventional radiology at Mt. Sinai Medical Center, New York. “This is a transformative technology that will enable more people who are suffering from DVT to have fast, effective minimally invasive therapy.”

In the study, 371 DVT patients were treated at 35 centers; 38 percent of treatments were completed in less than six hours and 76 percent in less than 24 hours. After 12 months, 81 percent of people remained free of DVT. Stents were placed in 116 patients (most in the pelvic arteries) to correct obstructions and prevent the future formation of clots.

The combination treatment involves giving DVT patients an intravenous catheter to introduce clot-busting drugs and then blasting the clot with high-pressure saline solution to break it up. A separate port on the catheter then vacuums up pieces of the clot and removes them from the body.

For more information: www.ISET.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now